Gilead Sciences (GILD) EPS (2009 - 2026)
Gilead Sciences (GILD) EPS from Mar 31, 2009 to Mar 31, 2026. The TTM Gilead Sciences (GILD) EPS is $7.42. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Gilead Sciences (GILD) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +55.00% |
| 3 Years TTM | +18.47% |
| 5 Years TTM | +98.59% |
| 10 Years TTM | -4.82% |
| All Time TTM | +10.03% |
Annual EPS change of Gilead Sciences (GILD)
| Year | EPS | Change |
|---|---|---|
| 2026 | $1.63 | -76.27% |
| 2025 | $6.86 | +1680.06% |
| 2024 | $0.39 | -91.53% |
| 2023 | $4.55 | +23.47% |
| 2022 | $3.68 | -25.82% |
| 2021 | $4.96 | +4960.98% |
| 2020 | $0.10 | -97.69% |
| 2019 | $4.25 | -0.02% |
| 2018 | $4.26 | +20.26% |
| 2017 | $3.54 | -65.67% |
| 2016 | $10.31 | -19.07% |
| 2015 | $12.73 | +57.74% |
| 2014 | $8.07 | +302.72% |
| 2013 | $2 | +17.49% |
| 2012 | $1.71 | -8.34% |
| 2011 | $1.86 | +2.91% |
| 2010 | $1.81 | +23.49% |
| 2009 | $1.46 | +34.68% |
| 2008 | $1.09 | N/A |
Comparison Gilead Sciences (GILD) five years EPS CAGR with competitors
Gilead Sciences (GILD) five years EPS CAGR is 98.59%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| LLY | Lilly(Eli) & Company | 29.14% | -70.44% |
| NVO | Novo Nordisk | 24.26% | -75.40% |
| AZN | Astrazeneca plc | 17.09% | -82.66% |
| NVS | Novartis AG | 14.96% | -84.83% |
| JNJ | Johnson & Johnson | 11.59% | -88.25% |
| MRK | Merck & Co Inc | 5.37% | -94.55% |
| BMY | Bristol-Myers Squibb Company | 5.08% | -94.85% |
| GSK | GSK Plc | 4.65% | -95.28% |
| AMGN | AMGEN Inc | 3.49% | -96.46% |